CAG
CVS icon

Csenge Advisory Group’s CVS Health CVS Stock Holding History

Csenge Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+2,414
New +$215K 0.01% 670
2024
Q4 		– Sell
-4,067
Closed -$271K – 708
2024
Q3 		$271K Sell
4,067
-226
-5% -$13.2K 0.01% 589
2024
Q2 		$254K Sell
4,293
-538
-11% -$33.7K 0.01% 556
2024
Q1 		$385K Sell
4,831
-21
-0.4% -$1.6K 0.02% 492
2023
Q4 		$383K Sell
4,852
-153
-3% -$10.9K 0.02% 473
2023
Q3 		$349K Sell
5,005
-8,705
-63% -$617K 0.02% 452
2023
Q2 		$948K Sell
13,710
-805
-6% -$57.3K 0.06% 223
2023
Q1 		$1.08M Buy
14,515
+1,426
+11% +$120K 0.08% 191
2022
Q4 		$1.22M Buy
13,089
+1,329
+11% +$128K 0.09% 188
2022
Q3 		$1.12M Sell
11,760
-1,034
-8% -$102K 0.09% 188
2022
Q2 		$1.19M Buy
12,794
+541
+4% +$52.8K 0.1% 176
2022
Q1 		$1.24M Buy
12,253
+4,172
+52% +$438K 0.1% 182
2021
Q4 		$664K Sell
8,081
-676
-8% -$62.5K 0.06% 277
2021
Q3 		$736K Buy
8,757
+676
+8% +$56.6K 0.06% 282
2021
Q2 		$664K Buy
8,081
+1,637
+25% +$134K 0.06% 278
2021
Q1 		$477K Sell
6,444
-755
-10% -$55K 0.05% 285
2020
Q4 		$492K Buy
7,199
+172
+2% +$11.2K 0.06% 226
2020
Q3 		$409K Buy
7,027
+2,957
+73% +$184K 0.06% 239
2020
Q2 		$264K Buy
+4,070
New +$256K 0.04% 298
2019
Q4 		– Sell
-3,871
Closed -$245K – 294
2019
Q3 		$245K Sell
3,871
-179
-4% -$10.6K 0.07% 230
2019
Q2 		$221K Sell
4,050
-195
-5% -$10.5K 0.08% 172
2019
Q1 		$228K Sell
4,245
-14,108
-77% -$871K 0.08% 178
2018
Q4 		$1.2M Buy
18,353
+3,964
+28% +$296K 0.44% 49
2018
Q3 		$1.15M Buy
14,389
+8,031
+126% +$574K 0.45% 46
2018
Q2 		$409K Buy
6,358
+1,340
+27% +$88.3K 0.15% 140
2018
Q1 		$312K Buy
5,018
+348
+7% +$25K 0.11% 190
2017
Q4 		$339K Buy
4,670
+1,720
+58% +$125K 0.12% 158
2017
Q3 		$240K Buy
+2,950
New +$233K 0.09% 206

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Csenge Advisory Group's CVS Position: Q2 2026 in Review

Csenge Advisory Group opened a new position in CVS Health (CVS) in Q2 2026: 2,414 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #670 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in CVS as recently as Q3 2024.

Csenge Advisory Group first reported a position in CVS in Q3 2017 and has held it in 28 quarters since. The position peaked at $1.24M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Csenge Advisory Group held 2,414 shares of CVS Health worth $250K as of Q2 2026.
  • CVS Health was a new Csenge Advisory Group position in Q2 2026.
  • CVS Health made up 0.01% of Csenge Advisory Group's portfolio in Q2 2026, its #670 holding.
  • Csenge Advisory Group first reported a position in CVS Health in Q3 2017 and has held it in 28 quarters since.
  • Csenge Advisory Group's CVS Health position peaked at $1.24M in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.